| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/16/2006 | EP1689394A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 08/16/2006 | EP1689389A2 Indole compounds |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689350A1 Use of osteopontin in dental formulations |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1397488B1 Novel compounds for chemiluminescense procedures |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 08/16/2006 | CN1820006A Substituted oxyarenes, and use thereof for controlling pests |
| 08/16/2006 | CN1817880A 2-bit-substituted quinolone compound and use in pharmacey |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091350 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091340 Thermodynamically stable |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091228 4-[4'-(1,3-Benzothiazol-2-ylamino)-1,1'-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acid and derivatives; inhibition of DGAT-1 (diacylglycerol O-acyltransferase type 1) |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091209 Dihydroxypyridmidine carboxylic acids as viral polymerase inhibitors |
| 08/15/2006 | US7091202 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide KCNQ potassium channel modulators |
| 08/15/2006 | US7091199 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
| 08/15/2006 | US7091198 2,5-disubstituted pyrimidine derivatives |
| 08/15/2006 | US7091196 triazoles and optionally carrier mixtures used for prohylaxis of infections, as antiproliferative agents, fungicides, bactericides, parasiticides, viricides, antiinflammatory agents and/or prokinetic agents (gastrointestinal modulatory) |
| 08/10/2006 | WO2006083781A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | WO2006083612A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | WO2006083454A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006082872A1 1-(piperidin-4-yl)-1h-indole derivative |
| 08/10/2006 | WO2006082822A1 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 08/10/2006 | WO2006082821A1 Preventive or therapeutic agent for herpesvirus-related disease |
| 08/10/2006 | WO2006082820A1 Therapeutic agent for herpes progenitalis |
| 08/10/2006 | WO2006082511A1 Novel salt form of a dopamine agonist |
| 08/10/2006 | WO2006082404A1 Compounds having tie2 (tek) inhibitory activity |
| 08/10/2006 | WO2006082392A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | WO2006082373A1 Pyrimidine compounds having ties (tek) inhibitory activity |
| 08/10/2006 | WO2006082371A1 Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 08/10/2006 | WO2006082354A1 Azacyclic compounds as inhibitors of sensory neurone specific channels ( sns ) |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006081659A1 Meroterpenoid inhibitors of phosphoinositide 3 kinase (pi3k) |
| 08/10/2006 | WO2006062982A3 Urea inhibitors of map kinases |
| 08/10/2006 | WO2006053778A3 Amide derivatives, their manufacture and use as pharmaceutical agents |
| 08/10/2006 | WO2006050359A3 Pyridazine compounds and methods |
| 08/10/2006 | WO2006044602A3 Diphenyl substituted alkanes as flap inhiibitors |
| 08/10/2006 | WO2005079496A3 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
| 08/10/2006 | US20060178513 Pyridinylanilides |
| 08/10/2006 | US20060178416 Quinoline derivatives as phosphodiesterase inhibitors |
| 08/10/2006 | US20060178412 [3-(Benzo[b]thiophene-2-carbonyl)-5-(4-methyl phenyl)-1H-indol-1-yl]-acetic acid, for treating conditions resulting from fibrinolytic disorders, such as deep vein thrombosis, coronary heart disease, and pulmonary fibrosis; Alzheimer's disease |
| 08/10/2006 | US20060178411 Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178408 Phosphodiesterases (PDE); for treating respiratory, nervous system, cardiovascular, inflammatory and allergic diseases, disorders and conditions as well as wounds |
| 08/10/2006 | US20060178405 Non-insulin dependent diabetes; 7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester; insulin-sensitizing activities |
| 08/10/2006 | US20060178403 Antiobesity agent, antidepressants, anxiolytic agents;3-[4-OXO-4H-THIENO[3,2-D]PYRIMIDIN-3-YL]-PYRROLIDINE-1-CARBOXYLIC ACID [1-(PYRROLIDIN-3-YL]-METHYL-AMIDES |
| 08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178370 Ketopiperazine derivatives as bradykinin antagonists |
| 08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178363 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 08/10/2006 | CA2596851A1 Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus |
| 08/10/2006 | CA2596850A1 Medicament for genital herpes |
| 08/10/2006 | CA2596686A1 Preventive or therapeutic agent for herpesvirus-related disease |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | CA2595834A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors |
| 08/10/2006 | CA2593858A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | CA2593788A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | CA2589328A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 08/09/2006 | EP1688412A2 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 08/09/2006 | EP1688408A2 Vanilloid receptor ligands and their use in treatments |
| 08/09/2006 | EP1687299A1 Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treamtment and/or prevention of disorders modulated by a ppar |
| 08/09/2006 | EP1687298A1 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones |
| 08/09/2006 | EP1687296A1 Antibacterial aminoquinazolidinedione derivatives |
| 08/09/2006 | EP1687295A2 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 08/09/2006 | EP1687294A2 Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3) |
| 08/09/2006 | EP1687284A2 p-38 KINASE INHIBITORS |
| 08/09/2006 | EP1687280A1 Cationic diaminopyrazoles, a method for the production thereof and dyes containing these compounds |
| 08/09/2006 | EP1687005A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 08/09/2006 | EP1687004A2 Pyridine compounds |
| 08/09/2006 | EP1687002A1 Fused heterocyclic compounds |
| 08/09/2006 | EP1686996A1 Quinazolinone compounds with reduced bioaccumulation |
| 08/09/2006 | EP1686987A2 Advanced indolinone based protein kinase inhibitors |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1317451B1 Chemokine receptor binding heterocyclic compounds |
| 08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
| 08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
| 08/09/2006 | CN1816548A Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816547A Oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816546A Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 08/09/2006 | CN1816545A Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816544A Immunosuppressant compounds and compositions |
| 08/09/2006 | CN1816534A Oxazolidinone antibiotics and derivatives thereof |
| 08/09/2006 | CN1816531A Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/09/2006 | CN1816529A Pyrazole-amide compounds useful as kinase inhibitors |
| 08/09/2006 | CN1816370A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |